These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 20457001)

  • 1. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
    Drewry DH; Macarron R
    Curr Opin Chem Biol; 2010 Jun; 14(3):289-98. PubMed ID: 20413343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Interweaving of Cheminformatics and HTS.
    Kümmel A; Parker CN
    Methods Mol Biol; 2011; 672():435-57. PubMed ID: 20838979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioprospecting microbial natural product libraries from the marine environment for drug discovery.
    Liu X; Ashforth E; Ren B; Song F; Dai H; Liu M; Wang J; Xie Q; Zhang L
    J Antibiot (Tokyo); 2010 Aug; 63(8):415-22. PubMed ID: 20606699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-world phenomena in chemical library networks: application to fragment-based drug discovery.
    Tanaka N; Ohno K; Niimi T; Moritomo A; Mori K; Orita M
    J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hit finding: towards 'smarter' approaches.
    Langer T; Hoffmann R; Bryant S; Lesur B
    Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivity-guided navigation of chemical space.
    Bon RS; Waldmann H
    Acc Chem Res; 2010 Aug; 43(8):1103-14. PubMed ID: 20481515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening for modulators of protein-protein interactions: use of photonic crystal biosensors and complementary technologies.
    Heeres JT; Hergenrother PJ
    Chem Soc Rev; 2011 Aug; 40(8):4398-410. PubMed ID: 21140010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fragment-based lead discovery from smaller fragments to functional ligand].
    Hatayama A; Habashita H
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1611-6. PubMed ID: 21089596
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular library design using multi-objective optimization methods.
    Nicolaou CA; Kannas CC
    Methods Mol Biol; 2011; 685():53-69. PubMed ID: 20981518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction of natural products library and its usage for drug discovery].
    Saito T; Nogawa T; Kato N; Kondoh Y; Osada H
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1551-6. PubMed ID: 21089587
    [No Abstract]   [Full Text] [Related]  

  • 16. Selecting chemicals: the emerging utility of DNA-encoded libraries.
    Clark MA
    Curr Opin Chem Biol; 2010 Jun; 14(3):396-403. PubMed ID: 20346729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothesis testing in high-throughput screening for drug discovery.
    Prummer M
    J Biomol Screen; 2012 Apr; 17(4):519-29. PubMed ID: 22233646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining for bioactive scaffolds with scaffold networks: improved compound set enrichment from primary screening data.
    Varin T; Schuffenhauer A; Ertl P; Renner S
    J Chem Inf Model; 2011 Jul; 51(7):1528-38. PubMed ID: 21615076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.